NCT02053857

Brief Summary

To test whether a ready-to-use therapeutic food (RUTF) enriched with polyunsaturated fatty acids (RUTF-P) is as effective for the treatment of severe acute malnutrition (SAM) as standard RUTF.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
141

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2014

Completed
1 day until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 4, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

September 29, 2014

Status Verified

September 1, 2014

Enrollment Period

5 months

First QC Date

January 31, 2014

Last Update Submit

September 26, 2014

Conditions

Keywords

severe acute malnutritionpolyunsaturated fatty acidsready-to-use therapeutic food

Outcome Measures

Primary Outcomes (2)

  • DHA Level

    Blood plasma docosahexaenoic acid (DHA) levels

    4 weeks

  • EPA Level

    Blood plasma eicosapentaenoic acid (EPA) levels

    4 weeks

Secondary Outcomes (4)

  • Recovery Rate

    12 weeks

  • Linear Growth

    12 weeks

  • Ponderal Growth

    12 weeks

  • Growth

    12 weeks

Study Arms (2)

RUTF

ACTIVE COMPARATOR

Standard RUTF at a dose of 175 kcal/kg/d

Dietary Supplement: RUTFDrug: Amoxicillin

RUTF-P

EXPERIMENTAL

RUTF fortified with polyunsaturated fatty acids (PUFA) at a dose of 175 kcal/kg/d

Dietary Supplement: RUTF-PDrug: Amoxicillin

Interventions

RUTFDIETARY_SUPPLEMENT
Also known as: ready-to-use therapeutic food
RUTF
RUTF-PDIETARY_SUPPLEMENT
RUTF-P
RUTFRUTF-P

Eligibility Criteria

Age6 Months - 59 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • kwashiorkor and/or marasmus
  • months of age
  • lives in local area near enrollment site

You may not qualify if:

  • recent (\<4 months) therapeutic feeding for moderate or severe acute malnutrition
  • chronic medical condition (eg, Down syndrome, other congenital syndrome, chronic heart disease) that may make feeding and growth difficult (not to include HIV or TB)
  • caretaker refusal of 2 blood draws
  • ineligibility for outpatient therapy (ie, severe illness or anorexia requiring inpatient therapy)
  • caretaker expresses plans to move away from local area of clinic, making followup difficult

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Malawi College of Medicine

Blantyre, Malawi

Location

MeSH Terms

Conditions

KwashiorkorProtein-Energy MalnutritionSevere Acute Malnutrition

Interventions

Amoxicillin

Condition Hierarchy (Ancestors)

MalnutritionNutrition DisordersNutritional and Metabolic DiseasesProtein DeficiencyDeficiency Diseases

Intervention Hierarchy (Ancestors)

AmpicillinPenicillin GPenicillinsbeta-LactamsLactamsAmidesOrganic ChemicalsSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Mark J Manary, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Kenneth Maleta, MBBS PhD

    University of Malawi

    PRINCIPAL INVESTIGATOR
  • Chrissie Thakwalakwa

    University of Malawi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2014

First Posted

February 4, 2014

Study Start

February 1, 2014

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

September 29, 2014

Record last verified: 2014-09

Locations